IA
CVS icon

IndexIQ Advisors’s CVS Health CVS Stock Holding History

IndexIQ Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.49M Sell
54,238
-6,669
-11% -$701K 0.19% 98
2021
Q4 		$6.28M Buy
60,907
+257
+0.4% +$23.7K 0.21% 79
2021
Q3 		$5.15M Buy
60,650
+595
+1% +$49.8K 0.17% 100
2021
Q2 		$5.01M Buy
60,055
+395
+0.7% +$32.3K 0.17% 97
2021
Q1 		$4.49M Buy
59,660
+9,437
+19% +$687K 0.16% 102
2020
Q4 		$3.43M Buy
50,223
+8,567
+21% +$557K 0.13% 115
2020
Q3 		$2.43M Buy
41,656
+5,704
+16% +$355K 0.1% 150
2020
Q2 		$2.34M Buy
35,952
+2,414
+7% +$152K 0.1% 142
2020
Q1 		$1.99M Sell
33,538
-44,403
-57% -$2.96M 0.09% 121
2019
Q4 		$5.79M Buy
77,941
+17,231
+28% +$1.21M 0.21% 71
2019
Q3 		$3.83M Sell
60,710
-20,775
-25% -$1.23M 0.14% 99
2019
Q2 		$4.44M Sell
81,485
-1,856
-2% -$99.9K 0.14% 126
2019
Q1 		$4.5M Buy
+83,341
New +$5.14M 0.13% 102

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IndexIQ Advisors's CVS Position: Q1 2022 in Review

IndexIQ Advisors reduced its CVS Health (CVS) stake by 11% in Q1 2022, selling an estimated $701K and leaving 54,238 shares worth $5.49M. The position accounts for 0.19% of the portfolio, ranked #98.

IndexIQ Advisors first reported a position in CVS in Q1 2019 and has held it in 13 quarters since. The position peaked at $6.28M in Q4 2021. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • IndexIQ Advisors held 54,238 shares of CVS Health worth $5.49M as of Q1 2022.
  • IndexIQ Advisors sold 6,669 CVS Health shares in Q1 2022, an estimated $701K.
  • CVS Health made up 0.19% of IndexIQ Advisors's portfolio in Q1 2022, its #98 holding.
  • IndexIQ Advisors first reported a position in CVS Health in Q1 2019 and has held it in 13 quarters since.
  • IndexIQ Advisors's CVS Health position peaked at $6.28M in Q4 2021.
  • 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.